UT-009 / Utopia Therapeutics - LARVOL DELTA

Hyderabad Biotech Utopia Therapeutics Secures US Patent for Immunotherapy-Based Obesity Vaccine (Medical Dialogues) - "The company’s lead candidate, UT-009, has been designed to stimulate the body’s immune system to generate specific antibodies targeting key pathways involved in fat accumulation and abnormal lipid levels...Utopia recently received US Patent No. 12,502,428 from the United States Patent and Trademark Office. The patent covers both the composition of the obesity vaccine and its methods of use, strengthening the company’s international intellectual property protection."

Patent • Obesity